-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Because of the limitations of the care of inflammatory bowel disease (IBD), there is a need to increase patient motivation and self-efficacy, which are associated with better health outcomes.
a multi-center, randomized controlled trial designed to assess changes in patient activation and general self-efficacy from baseline to 12 months through the TELEmedicine for IBD trial.
the trial included a web-based monitoring system that interacted with participants via text message.
222 IBD adults experienced IBD seizures in the two years before the trial were randomly divided into control groups receiving standard care (SC) or intervention groups that completed self-tests every other week (EOW) or weekly (W) through the TELE-IBD system.
results showed no significant difference in self-efficacy scores between the control group and the experimental group.
significant difference in patient activation scores between only the standard care group and the TELE-IBD EOW group (P s 0.03).
, the results showed that the use of remote monitoring did not improve self-efficacy and patient activation compared to routine care.
.